Rosalind Advisors, Inc. CGON — CG ONCOLOGY INC

Ownership history in Rosalind Advisors, Inc.  ·  4 quarters on record

AI Ownership Summary

Rosalind Advisors, Inc. reported CG ONCOLOGY INC (CGON) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. Peak portfolio weight reached 4.38% in 2025 Q4. The latest visible filing shows CGON at 2.72% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CGON ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Rosalind Advisors, Inc.'s position in CG ONCOLOGY INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CGON was reported at 2.72% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
4.38% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CGON stock page Rosalind Advisors, Inc. fund profile Rosalind Advisors, Inc. full holdings
How Rosalind Advisors, Inc. held CGON — position size vs. price
% of Fund (quarterly)    CGON price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 100,000 -200,000 -66.7% 2.72% $6.8M 2026-05-14 $69.54
2025 Q4 UNCHANGED — — — 300,000 — 0% 4.38% $12.5M 2026-02-12 $51.62
2025 Q3 ADDED — — — 300,000 +107,026 +55.5% 4.13% $12.1M 2025-11-13 $37.76
2025 Q2 INITIATED — — — 192,974 — — 2.38% $5.0M 2025-08-14 $25.96

🏢 Other funds also holding CGON

As of 2026 Q1 — sorted by position size

Decheng Capital LLC 65.21% Foresite Capital Management VI LLC 32.67% Seven Fleet Capital Management LP 30.92% Foresite Capital Management V, LLC 3Y 25.08% ACORN CAPITAL ADVISORS, LLC 21.77% TCG Crossover Management, LLC 3Y 7.11% Elmind Capital, LP 5.61% RTW INVESTMENTS, LP 3Y 7Y 4.7% Caligan Partners LP 3Y 4.05% EcoR1 Capital, LLC 3Y 7Y 3.17%

FAQ About Rosalind Advisors, Inc. and CGON

These are the practical questions this page is built to answer before you even open the full history table.

How long has Rosalind Advisors, Inc. reported owning CGON?

Rosalind Advisors, Inc. reported CGON across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported CGON position in Rosalind Advisors, Inc.'s portfolio?

The largest reported portfolio weight for CGON was 4.38% in 2025 Q4.

What is the latest reported CGON position on this page?

The most recent filing on this page is 2026 Q1, when Rosalind Advisors, Inc. reported 100,000 shares, equal to 2.72% of portfolio, with an estimated market value of $6.8M.

What does the chart on this CGON ownership page compare?

The chart compares Rosalind Advisors, Inc.'s quarterly CGON portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Rosalind Advisors, Inc. Holdings